Aduro Clean Technologies Provides Update on Joint Western University Research Project
LONDON, Ontario, April 04, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) […]
ZeroFox Wins Multiple Industry Awards and Reinforces Digital Risk Protection Leadership Position
20th Annual Globee® Awards for Cybersecurity and G2’s 2024 Spring Report honor ZeroFox’s innovative Brand and Domain Protection capabilities WASHINGTON, […]
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Dose escalation in Phase 1b trial completed with no dose-limiting toxicities, no or low-grade cytokine release syndrome and no immune […]
ScottsMiracle-Gro Provides Update on Fiscal 2024 Second Quarter
MARYSVILLE, Ohio, April 04, 2024 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded […]
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
– Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma – – Improved […]
Oculis to Participate at Upcoming April Investor Conferences
ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company […]
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
– Improved VELOS™ manufacturing process delivering higher cNeT doses – – Protocols updated to evaluate the benefit of enhanced host conditioning, […]
Brunswick Corporation Schedules First Quarter Earnings Conference Call
METTAWA, Ill., April 04, 2024 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) will release its first quarter financial results on […]
Niu Technologies Provides First Quarter 2024 Sales Volume Update
BEIJING, China, April 04, 2024 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider […]
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are […]
